dermanostic has secured €4 million in Pre-Series A funding led by DvH Ventures to expand its digital dermatology services across Europe.
Target Information
dermanostic is a prominent telemedicine provider specializing in digital dermatology in Germany. The platform offers an innovative approach that allows patients to submit photos and a brief medical questionnaire through its application, receiving a specialist diagnosis rapidly—often within hours. This service includes prescription options when necessary, all while ensuring high medical standards through a model supported by over 20 board-certified dermatologists.
As one of Germany's leading digital dermatology platforms, dermanostic's mission is to enhance the efficiency and accessibility of dermatological care. Its unique asynchronous treatment model ensures that patients can swiftly access expert medical opinions, thus addressing the growing demand for remote healthcare solutions.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Germany
The digital healthcare industry in Germany has shown remarkable growth, driven by an increasing need for accessible healthcare services and the ongoing digital transformatio
Similar Deals
High-Tech Gründerfonds → Sedivention
2024
Anobis Asset, Bayern Kapital, UnternehmerTUM Funding for Innovators, HTGF – High-Tech Gründerfonds, Boehringer Ingelheim Venture Fund → smartbax
2023
athagoras → DiaMed Beratungsgesellschaft für pharmazeutische Unternehmen mbH
2025
Dieter von Holtzbrinck Ventures
invested in
dermanostic
in 2025
in a Pre-Seed Stage deal
Disclosed details
Transaction Size: $4M